Role of the xenobiotic receptor in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 17, Issue 5, 2011, Pages 1149-1162

  Arsenescu, Razvan ^a   Arsenescu, Violeta ^a,b   Zhong, Jian ^a   Nasser, Munira ^a   Melinte, Razvan ^c   Dingle, R W Cameron ^b   Swanson, Hollie ^b   De Villiers, Willem J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University Hospital Tg Mures   (Romania)

Author keywords

adiponectin; angiotensin; aryl hydrocarbon receptor; ER stress; inflammatory bowel diseases; Th1; Th17; Th2

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; ENTERITIS; INTESTINE MUCOSA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOKING CESSATION; UPREGULATION; WILD TYPE; XENOBIOTIC STRESS;

ADIPONECTIN; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOPSY; COLITIS; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, ARYL HYDROCARBON; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TH2 CELLS; XENOBIOTICS;

EID: 79952795776     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21463     Document Type: Article

References (61)

1. Marquez A, Orozco G, Martinez A, et al. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am J Gastroenterol. 2009; 104: 1968-1975.
2. Arsenescu R, Bruno ME, Kaetzel CS, et al. Signature biomarkers in Crohn's disease: toward a molecular classification. Mucosal Immunol. 2008; 1: 399-411.
3. Bjorksten B,. Disease outcomes as a consequence of environmental influences on the development of the immune system. Curr Opin Allergy Clin Immunol. 2009; 9: 185-189.
4. Longstreth GF, Thompson WG, Spiller RC, et al. Functional bowel disorders. Gastroenterology. 2006; 130: 1480-1491.
5. Bhat M, Nguyen GC, Pare P, et al. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am J Gastroenterol. 2009; 104: 2233-2240.
6. Calkins BM,. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989; 34: 1841-1854. (Pubitemid 20018648)
7. Kitamura M, Kasai A,. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Lett. 2007; 252: 184-194. (Pubitemid 46809788)
8. Kasai A, Hiramatsu N, Kitamura M, et al. High levels of dioxin-like potential in cigarette smoke evidenced by in vitro and in vivo biosensing. Cancer Res. 2006; 66: 7143-7150. (Pubitemid 44197692)
9. Stevens EA, Mezrich JD, Bradfield CA,. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology. 2009; 127: 299-311.
10. Quintana FJ, Cohen IR,. Regulatory T cells and immune computation. Eur J Immunol. 2008; 38: 903-907.
11. Ho PP, Steinman L,. The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in disease. Cell Res. 2008; 18: 605-608. (Pubitemid 351793116)
12. Thatcher TH, Maggirwar SB, Baglole CJ, et al. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am J Pathol. 2007; 170: 855-864. (Pubitemid 47339355)
13. Swanson HI, Bradfield CA,. The AH-receptor: genetics, structure and function. Pharmacogenetics. 1993; 3: 213-230. (Pubitemid 23333091)
14. Minami K, Nakajima M, Yokoi T, et al. Regulation of insulin-like growth factor binding protein-1 and lipoprotein lipase by the aryl hydrocarbon receptor. J Toxicol Sci. 2008; 33: 405-413.
15. Shimba S, Watabe Y,. Crosstalk between the AHR signaling pathway and circadian rhythm. Biochem Pharmacol. 2009; 77: 560-565.
16. Marshall NB, Kerkvliet NI,. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann N Y Acad Sci. 2010; 1183: 25-37.
17. Currier N, Solomon SE, Demicco EG, et al. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol. 2005; 33: 726-737. (Pubitemid 43154600)
18. Andersson P, McGuire J, Rubio C, et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci U S A. 2002; 99: 9990-9995. (Pubitemid 34831160)
19. Ten Hove T, Corbaz A, Amitai H, et al. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology. 2001; 121: 1372-1379. (Pubitemid 33140454)
20. Mizoguchi E, Podolsky DK, Mizoguchi A, et al. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology. 2003; 125: 148-161. (Pubitemid 36799116)
21. Hug C, Tsao TS, Lodish HF, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A. 2004; 101: 10308-10313. (Pubitemid 38924921)
22. Lee AS,. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods. 2005; 35: 373-381. (Pubitemid 40445371)
23. Lee AH, Iwakoshi NN, Glimcher LH,. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003; 23: 7448-7459. (Pubitemid 37271447)
24. Podechard N, Lecureur V, Fardel O, et al. Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. Toxicol Lett. 2008; 177: 130-137.
25. Bagaitkar J, Demuth DR, Scott DA,. Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis. 2008; 4: 12.
26. Mahid SS, Stromberg AJ, Galandiuk S, et al. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 431-438. (Pubitemid 46668248)
27. Arsenescu V, Arsenescu RI, Cassis LA, et al. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect. 2008; 116: 761-768. (Pubitemid 351943932)
28. Bohonowych JE, Denison MS,. Persistent binding of ligands to the aryl hydrocarbon receptor. Toxicol Sci. 2007; 98: 99-109. (Pubitemid 47073824)
29. Mandal PK,. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol B. 2005; 175: 221-230. (Pubitemid 40764087)
30. Kerkvliet NI, Oughton JA,. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol. 1993; 119: 248-257. (Pubitemid 23122835)
31. Pande K, Moran SM, Bradfield CA,. Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines. Mol Pharmacol. 2005; 67: 1393-1398. (Pubitemid 40594137)
32. Moos AB, Oughton JA, Kerkvliet NI,. The effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) on tumor necrosis factor (TNF) production by peritoneal cells. Toxicol Lett. 1997; 90: 145-153. (Pubitemid 27096529)
33. Vogel CF, Nishimura N, Matsumura F, et al. Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch Biochem Biophys. 2007; 461: 169-175. (Pubitemid 46677883)
34. Kimura A, Naka T, Nakahama T, et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med. 2009; 206: 2027-2035.
35. Sekine H, Mimura J, Oshima M, et al. Hypersensitivity of AhR-deficient mice to LPS-induced septic shock. Mol Cell Biol. 2009; 29: 6391-6400.
36. Kawajiri K, Kobayashi Y, Ohtake F, et al. Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc Natl Acad Sci U S A. 2009; 106: 13481-13486.
37. Ray SS, Swanson HI,. Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J Biol Chem. 2004; 279: 27187-27193. (Pubitemid 38812555)
38. Puga A, Marlowe J, Barnes S, et al. Role of the aryl hydrocarbon receptor in cell cycle regulation. Toxicology. 2002; 181-182: 171-177. (Pubitemid 36015693)
39. Marlowe JL, Fan Y, Chang X, et al. The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell. 2008; 19: 3263-3271.
40. Vogel CF, Sciullo E, Matsumura F,. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochem Biophys Res Commun. 2007; 363: 722-726. (Pubitemid 47513689)
41. Vogel CF, Matsumura F,. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochem Pharmacol. 2009; 77: 734-745.
42. Shimada T, Hiramatsu N, Hayakawa K, et al. Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress. Am J Physiol Endocrinol Metab. 2009; 296: E721-730.
43. Kamada N, Hisamatsu T, Okamoto S, et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest. 2008; 118: 2269-2280. (Pubitemid 351872344)
44. Pache I, Rogler G, Felley C,. TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guide. Swiss Med Wkly. 2009; 139: 278-287.
45. Tilg H, Moschen A, Kaser A,. Mode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseases. Expert Opin Biol Ther. 2007; 7: 1051-1059. (Pubitemid 47204358)
46. Esser C,. The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. Biochem Pharmacol. 2009; 77: 597-607.
47. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008; 453: 65-71. (Pubitemid 351630328)
48. Brand S,. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut. 2009; 58: 1152-1167.
49. Bai A, Chen J, Peng Z, et al. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol. 2009; 86: 959-969.
50. Cassis LA, Lu H, Daugherty A, et al. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol. 2007; 27: 380-386. (Pubitemid 46143055)
51. Jaszewski R, Tolia V, Ehrinpreis MN, et al. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis. Gastroenterology. 1990; 98: 1543-1548. (Pubitemid 20158619)
52. Santiago OI, Rivera E, Appleyard CB, et al. An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis. Regul Pept. 2008; 146: 250-259.
53. Nishihara T, Matsuda M, Araki H, et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology. 2006; 131: 853-861. (Pubitemid 44307068)
54. Wolf AM, Enrich B, Tilg H, et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004; 323: 630-635. (Pubitemid 39221142)
55. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008; 134: 743-756.
56. Shkoda A, Ruiz PA, Daniel H, et al. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology. 2007; 132: 190-207. (Pubitemid 46108743)
57. Horikawa K, Oishi N, Nakagawa J, et al. Novel potential of tunicamycin as an activator of the aryl hydrocarbon receptor - dioxin responsive element signaling pathway. FEBS Lett. 2006; 580: 3721-3725. (Pubitemid 43902809)
58. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008; 453: 106-109. (Pubitemid 351630329)
59. Esser C, Rannug A, Stockinger B,. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009; 30: 447-454.
60. Stockinger B, Veldhoen M, Hirota K,. Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor-the role of endogenous ligands. Eur J Immunol. 2009; 39: 652-654.
61. Sciullo E, Vogel C, Li W, Matsumura F, et al. Initial and extended inflammatory messages of the nongenomic signaling pathway of the TCDD-activated Ah receptor in U937 macrophages. Arch Biochem Biophys. 2008; 480: 143-155.